IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 7290 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

EDITORIAL

Fixed dose drug combinations: Issues and challenges in India

Gupta Yogendra Kumar, Ramachandran Suganthi S

Year : 2016| Volume: 48| Issue : 4 | Page no: 347-349

   This article has been cited by
 
1 Identification of At-risk Pregnant Population for Over-the-Counter Drug Usage in Low-Resource Settings
Aashima Arora, M. Praveen Kumar, Aishwarya Anand, Lekha Saha, Pradip Kumar Saha, Ankit Kumar, Haresh Shendge, Amol N. Patil
The Journal of Obstetrics and Gynecology of India. 2021; 71(6): 600
[Pubmed]  [Google Scholar] [DOI]
2 Communication with Physicians: a Tool for Improving Appropriate Antibiotic Use in the Absence of Regulatory Mechanisms
Purabi Barman, Tarun Thukral, Shimpi Chopra
Current Treatment Options in Infectious Diseases. 2021; 13(1): 1
[Pubmed]  [Google Scholar] [DOI]
3 Antibiotic Use and Misuse in Dentistry in India—A Systematic Review
Aarthi Bhuvaraghan, Rebecca King, Harriet Larvin, Vishal R. Aggarwal
Antibiotics. 2021; 10(12): 1459
[Pubmed]  [Google Scholar] [DOI]
4 Fixed-dose combinations: An essential for rational preparation
Pugazhenthan Thangaraju, ShobanBabu Varthya, Sajitha Venkatesan
Indian Journal of Pharmacology. 2021; 53(2): 170
[Pubmed]  [Google Scholar] [DOI]
5 Indian Pharmaceutical Industries Current Status and Togetherness to Overcome Speed Breakers in Term of Quality Issues to make India as a Global Pharma Destination
Vikas Rathee, Kapil Pihwal, Neelam Pawar, Sheikh Aamir, Mohammad S. Alam, Kavita Bahmani
Applied Drug Research, Clinical Trials and Regulatory Affairs. 2021; 8(1): 19
[Pubmed]  [Google Scholar] [DOI]
6 Ofloxacin-ornidazole fixed-dose combination medication-induced pancreatitis with positive rechallenge
Nikhil Bush, Vishal Sharma, K Chandrahasan, AmolN Patil
Journal of Family Medicine and Primary Care. 2020; 9(6): 3157
[Pubmed]  [Google Scholar] [DOI]
7 Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel
Sanjay Kalra, AK Das, G Priya, S Ghosh, RN Mehrotra, S Das, P Shah, S Bajaj, V Deshmukh, D Sanyal, S Chandrasekaran, D Khandelwal, A Joshi, T Nair, F Eliana, H Permana, MD Fariduddin, PK Shrestha, D Shrestha, S Kahandawa, M Sumanathilaka, A Shaheed, AA Rahim, A Orabi, A Al-ani, W Hussein, D Kumar, K Shaikh
Journal of Family Medicine and Primary Care. 2020; 9(11): 5450
[Pubmed]  [Google Scholar] [DOI]
8 Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
Brian Godman, Holly McCabe, Trudy D Leong, Debjani Mueller, Antony P. Martin, Iris Hoxha, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Amos Massele, Juliana de Oliveira Costa, Renata Cristina Rezende Macedo do Nascimento, Livia Lovato Pires de Lemos, Konstantin Tachkov, Petya Milushewa, Okwen Patrick, Loveline Lum Niba, Ott Laius, Israel Sefah, Suhaj Abdulsalim, Fatemeh Soleymani, Anastasia N Guantai, Loice Achieng, Margaret Oluka, Arianit Jakupi, Konstantins Logviss, Mohamed Azmi Hassali, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Zikria Saleem, Shazhad Hussain, Tomasz Bochenek, Ileana Mardare, Alian A. Alrasheedy, Jurij Furst, Dominik Tomek, Vanda Markovic-Pekovic, Enos M. Rampamba, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Thuy Nguyen Thi Phuong, Binh Nguyen Thanh, Aubrey Chichonyi Kalungia, Trust Zaranyika, Nyasha Masuka, Ioana D. Olaru, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell, Johanna C. Mey
Expert Review of Pharmacoeconomics & Outcomes Research. 2020; 20(1): 1
[Pubmed]  [Google Scholar] [DOI]
9 Developing a latent class analysis model to identify at-risk populations among people using medicine without prescription
Praveen Kumar-M, Rahul Mahajan, S Kathirvel, Naveen Hegde, Ashish Kumar Kakkar, Amol N. Patil
Expert Review of Clinical Pharmacology. 2020; 13(12): 1411
[Pubmed]  [Google Scholar] [DOI]
10 Unorthodox Parenteral ß-Lactam and ß-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care
Snehal Palwe, Balaji Veeraraghavan, Hariharan Periasamy, Kshama Khobragade, Arun S. Kharat
Antimicrobial Agents and Chemotherapy. 2020; 64(5)
[Pubmed]  [Google Scholar] [DOI]
11 Pharmaceutical Market and Drug Price Policy in India
Venkatanarayana Motkuri, Rudra Narayan Mishra
Review of Development and Change. 2020; 25(1): 30
[Pubmed]  [Google Scholar] [DOI]
12 Importance of patents and data exclusivity in fixed-dose combination medicinal products
Marija Mitkovska, Katerina Anchevska Netkovska, Aleksandra Grozdanova, Ana Poceva Panovska, Ema Kikovska Stojanovska
Macedonian Pharmaceutical Bulletin. 2019; 65(2): 33
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow